BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36920100)

  • 1. The importance of infertility duration and follicle size according to pregnancy success in women undergoing ovulation induction with gonadotropins and intrauterine insemination.
    Kuru Pekcan M; Tokmak A; Ulubasoglu H; Kement M; Özakşit G
    J Obstet Gynaecol; 2023 Dec; 43(1):2173058. PubMed ID: 36920100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of two different starting doses of recombinant follicle stimulating hormone (rFSH) for intrauterine insemination (IUI) cycles in non-obese women with polycystic ovary syndrome (PCOS): a retrospective cohort study.
    Seckin B; Yumusak OH; Tokmak A
    J Obstet Gynaecol; 2021 Nov; 41(8):1234-1239. PubMed ID: 33624571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated day 3 follicle-stimulating hormone in younger women: is gonadotropin stimulation/intrauterine insemination a good option?
    Souter I; Dimitriadis I; Baltagi LM; Meeker JD; Petrozza JC
    Am J Obstet Gynecol; 2014 Jul; 211(1):62.e1-8. PubMed ID: 24487006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ovulation induction and intrauterine insemination in infertile patients with hypogonadotropic hypogonadism.
    Huseyin K; Berk B; Tolga K; Eser O; Ali G; Murat A
    J Gynecol Obstet Hum Reprod; 2019 Dec; 48(10):833-838. PubMed ID: 30930300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
    Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
    Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do younger women with elevated basal follicular stimulating hormone levels undergoing gonadotropin-stimulated intrauterine insemination cycles represent compromised reproductive outcomes?
    Devranoğlu B; Özdamar Ö; Köle E; Eken MK; Bozdağ H; Doğer E
    Eur J Obstet Gynecol Reprod Biol; 2016 Apr; 199():141-5. PubMed ID: 26930042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An effective alternative to only gonadotrophin for controlled ovarian stimulation in unexplained infertility patients undergoing intra-uterine insemination: a clinical trial.
    Chaudhury K; Chaudhury S; Khastgir G; Purakaystha S
    J Indian Med Assoc; 2013 Sep; 111(9):589-92, 594. PubMed ID: 24968520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of preconceptional serum thyroid stimulating hormone values ranging between 2.5 and 4.5 mIU/L on live birth rates following ovulation induction and intrauterine insemination treatment for unexplained infertility.
    Karakis LS; Kiyak H; Okmen B; Ozdemir C; Turkgeldi E
    BMC Womens Health; 2021 Apr; 21(1):162. PubMed ID: 33874925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does intrauterine insemination timing matter for achieving pregnancy during ovulation induction using gonadotropins? A retrospective cohort study.
    Yumusak OH; Kahyaoglu S; Pekcan MK; Isci E; Cinar M; Tasci Y
    J Chin Med Assoc; 2017 Jun; 80(6):366-370. PubMed ID: 27686502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulocyte colony stimulating factor (GCSF) did not affect the fertility outcomes in women with unexplained infertility after intrauterine insemination: a randomised clinical trial.
    Aramesh S; Azizi Kutenaee M; Najafi F; Ghaffari P; Taghavi SA
    J Obstet Gynaecol; 2022 Aug; 42(6):2480-2485. PubMed ID: 35787135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advantages of recombinant follicle-stimulating hormone over human menopausal gonadotropin for ovarian stimulation in intrauterine insemination: a randomized clinical trial in unexplained infertility.
    Rashidi M; Aaleyasin A; Aghahosseini M; Loloi S; Kokab A; Najmi Z
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):244-7. PubMed ID: 23541417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gonadotropins and endometrial thickness on pregnancy outcome in patients with unexplained infertility or polycystic ovarian syndrome undergoing intrauterine insemination.
    Li Q; Zhu M; Deng Z; Wang L; Huang Y; Ruan L; Hu S; Wang L
    J Int Med Res; 2020 Oct; 48(10):300060520966538. PubMed ID: 33121310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of low-dose human chorionic gonadotropin combined with human menopausal gonadotropin protocol on women with hypogonadotropic hypogonadism undergoing ovarian stimulation for in vitro fertilization.
    Jiang S; Kuang Y
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):77-87. PubMed ID: 28960429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homologous intrauterine insemination in controlled ovarian hyperstimulation cycles: a comparison among three different regimens.
    Casadei L; Zamaro V; Calcagni M; Ticconi C; Dorrucci M; Piccione E
    Eur J Obstet Gynecol Reprod Biol; 2006 Dec; 129(2):155-61. PubMed ID: 16687201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine insemination performance characteristics and post-processing total motile sperm count in relation to live birth for couples with unexplained infertility in a randomised, multicentre clinical trial.
    Hansen KR; Peck JD; Coward RM; Wild RA; Trussell JC; Krawetz SA; Diamond MP; Legro RS; Coutifaris C; Alvero R; Robinson RD; Casson P; Christman GM; Santoro N; Zhang H
    Hum Reprod; 2020 Jun; 35(6):1296-1305. PubMed ID: 32432326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of GnRH antagonists on clinical pregnancy rates in ovulation induction protocols with gonadotropins and intrauterine insemination.
    Dansuk R; Gonenc AI; Sudolmus S; Yucel O; Sevket O; Köroğlu N
    Singapore Med J; 2015 Jun; 56(6):353-6. PubMed ID: 25532515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antral follicle count predicts the outcome of pregnancy in a controlled ovarian hyperstimulation/intrauterine insemination program.
    Chang MY; Chiang CH; Chiu TH; Hsieh TT; Soong YK
    J Assist Reprod Genet; 1998 Jan; 15(1):12-7. PubMed ID: 9493060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of follicle size on pregnancy outcomes in patients undergoing first letrozole-intrauterine insemination.
    Ling L; Xia D; Jin Y; Hong R; Wang J; Liang Y
    Eur J Med Res; 2024 Mar; 29(1):184. PubMed ID: 38500174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovulation induction and intrauterine insemination in infertile women with polycystic ovary syndrome: A comparison of drugs.
    Huang S; Du X; Wang R; Li R; Wang H; Luo L; O'Leary S; Qiao J; Mol BWJ
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():117-121. PubMed ID: 30366343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.